Recently, there have been many exciting events in the U.S. stock market:

$Premium Catering(PC.US) is about to release its Q3 earnings report. The stock price has already surged in the past two days, with a cumulative increase of up to 51%, drawing intense attention from many investors! Moreover, the company delayed submitting its quarterly report due to audit reviews and restatements of the last two quarters' financials, so the "water content" of the earnings report is hard to gauge—the suspense is even more intense than following a drama.

The biotech sector also has highlights: $CRISPR Therap(CRSP.US) announced progress in gene-editing therapies for rare diseases and high cholesterol treatment, reigniting market speculation about its explosive potential and attracting significant short-term attention.

$Intuitive Machines(LUNR.US) board members have been increasing their holdings, spending nearly $1.3 million in the last two transactions. Everyone is guessing whether this is due to insider information or genuine confidence in the company.

As for $Unity Software(U.US), it has gained over 50% this year, but recent market debates about its valuation have intensified. The tech and gaming communities are watching closely to see if it can continue to outperform after its strategic adjustments.

Finally, $Datto(MSP.US) has no major news for now.

Overall, PACS's earnings disclosure and reporting delay have the biggest short-term impact. Other companies either have executive changes or are in the spotlight for their technological focus. Under the current bullish sentiment, who do you think is most likely to outperform the market? Will you chase PACS's rally, or are you more bullish on CRSP's biotech logic? Share your thoughts and plans—don’t let the veterans ride alone!